Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. This gene, and also the SSX1 and SSX4 family members, have been involved in t(X;18)(p11.2;q11.2) translocations that are characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are likely responsible for transforming activity. Alternative splicing of this gene results in multiple transcript variants. This gene also has an identical duplicate, GeneID: 727837, located about 45 kb downstream in the opposite orientation on chromosome X.
Gene Name: | Synovial sarcoma, X breakpoint 2 |
Synonyms: | SSX2, CT5.2a, Cancer/testis antigen 5.2, CT5.2, HOM-MEL-40, Protein SSX2, SSX2A, SSX, Hd21, Tumor antigen HOM-MEL-40 |
Target Sequences: | NM_003147 NP_003138.3 Q16385 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.